Thalassemia and Sickle Cell Society (TSCS) always stands forefront in providing blood transfusion free of cost for Thalassemia Blood disorders patients
iNCOVACC was developed in partnership with Washington University St. Louis, which had designed and developed the recombinant adenoviral vectored constructs and evaluated them in preclinical studies for efficacy
The drive also conducted a mega health camp, cancer screening for women and men, ENT screening for children, and blood donation drive
States were also strongly advised to strictly monitor epidemiological profile of admitted COVID patients
Site has a capital investment program of ~$30 million spent or committed over the last three years to expand capabilities and improve operational efficiencies
Increased and timely testing will enable early identification of COVID cases and help to curb spread of the infection among the community
The second phase of the orientation workshop is being organized to provide in-depth knowledge to the state officials on core building blocks of ABDM
The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs
The company also raised Rs 270 crore investment from Temasek in 2019
TSCS appeals to the Govt. of Telangana to release a G.O for mandatory antenatal test - HbA2 for every pregnant woman to help prevent the birth of Thalassemia Major Children for the well-being of their family & Telangana State
Subscribe To Our Newsletter & Stay Updated
